Experimental cell therapy aims to boost immune system against Hard-to-Treat prostate cancer

NCT ID NCT06056791

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This early-phase trial tested an experimental cell therapy called INKmune in 12 men with advanced prostate cancer that no longer responds to hormone therapy. The goal was to find the safest and most effective dose by measuring immune cell activity, PSA levels, and tumor changes. The treatment is given as three intravenous doses, and the study focused on safety and signs of disease control.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary โ€” we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer castration-resistant prostate carcinoma metastatic prostate carcinoma neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Carl & Edyth Lindner Center for Research and Education at The Christ Hospital and The Christ Hospital Cancer Center

    Cincinnati, Ohio, 45219, United States

  • Comprehensive Cancer Centers of Nevada

    Las Vegas, Nevada, 89169, United States

  • NEXT Virginia

    Fairfax, Virginia, 22031, United States

  • Renovatio Clinical

    El Paso, Texas, 79915, United States

  • Renovatio Clinical

    The Woodlands, Texas, 77380, United States

  • University of California, Los Angeles

    Los Angeles, California, 90095, United States

  • VA Greater Los Angeles Healthcare System

    Los Angeles, California, 90073, United States

  • VA Puget Sound Health Care System

    Seattle, Washington, 98108, United States